FUSION PROTEINS AND USE THEREOF IN THE TREATMENT OF MEMBRANOUS NEPHROPATHY
There are disclosed fusion proteins comprising an anti-CD3 antibody and an autoantigen involved in autoimmune diseases, nucleic acid encoding the same, pharmaceutical composition comprising them and the use thereof for the treatment of autoimmune diseases and particularly of membranous nephropathy..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 06. März Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
PERICO LUCA [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-06, Last update posted on www.tib.eu: 2024-04-09, Last updated: 2024-04-15 |
---|
Patentnummer: |
EP4330273 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA001570293 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA001570293 | ||
003 | DE-627 | ||
005 | 20240415110824.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240322s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA001570293 | ||
035 | |a (EPA)EP4330273 | ||
035 | |a (EPA)75746379 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a PERICO LUCA |e verfasserin |4 aut | |
245 | 1 | 0 | |a FUSION PROTEINS AND USE THEREOF IN THE TREATMENT OF MEMBRANOUS NEPHROPATHY |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-06, Last update posted on www.tib.eu: 2024-04-09, Last updated: 2024-04-15 | ||
520 | |a There are disclosed fusion proteins comprising an anti-CD3 antibody and an autoantigen involved in autoimmune diseases, nucleic acid encoding the same, pharmaceutical composition comprising them and the use thereof for the treatment of autoimmune diseases and particularly of membranous nephropathy. | ||
650 | 4 | |a bio | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a CASIRAGHI FEDERICA |e verfasserin |4 aut | |
700 | 0 | |a BENIGNI ARIELA |e verfasserin |4 aut | |
700 | 0 | |a REMUZZI GIUSEPPE |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 06. März |
773 | 1 | 8 | |g year:2024 |g day:06 |g month:03 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/75746379/publication/EP4330273A1?q=EP4330273 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2024 |b 06 |c 03 |